Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease

BACKGROUND: This is a real-world evidence study that aims to analyze the efficacy, tolerability and safety profile of paritaprevir/ombitasvir/ritonavir and dasabuvir, in patients with renal impairment. METHODS: We conducted an observational prospective study, on 232 patients with chronic kidney dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Iliescu, Elena Laura, Mercan-Stanciu, Adriana, Toma, Letitia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966843/
https://www.ncbi.nlm.nih.gov/pubmed/31948406
http://dx.doi.org/10.1186/s12882-020-1687-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966843/
https://www.ncbi.nlm.nih.gov/pubmed/31948406
http://dx.doi.org/10.1186/s12882-020-1687-1

Ejemplares similares